{"protocolSection": {"identificationModule": {"nctId": "NCT03245255", "orgStudyIdInfo": {"id": "R21HL130899", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/R21HL130899"}, "secondaryIdInfos": [{"id": "R21HL130899", "type": "NIH", "link": "https://reporter.nih.gov/quickSearch/R21HL130899"}], "organization": {"fullName": "Thomas Jefferson University", "class": "OTHER"}, "briefTitle": "Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound", "officialTitle": "Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound"}, "statusModule": {"statusVerifiedDate": "2024-05", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2017-12-04", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2020-09-18", "type": "ACTUAL"}, "completionDateStruct": {"date": "2023-06-07", "type": "ACTUAL"}, "studyFirstSubmitDate": "2017-08-04", "studyFirstSubmitQcDate": "2017-08-07", "studyFirstPostDateStruct": {"date": "2017-08-10", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2021-12-15", "resultsFirstSubmitQcDate": "2024-05-01", "resultsFirstPostDateStruct": {"date": "2024-05-29", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2024-05-01", "lastUpdatePostDateStruct": {"date": "2024-05-29", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Thomas Jefferson University", "class": "OTHER"}, "collaborators": [{"name": "National Heart, Lung, and Blood Institute (NHLBI)", "class": "NIH"}, {"name": "GE Healthcare", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "This study will use contrast echocardiography to assess the accuracy of a new non-invasive imaging method for subharmonic aided pressure estimation (SHAPE) compared to simultaneously acquired intra-cardiac pressures measured invasively during cardiac catheterization. This study is designed to verify that contrast echocardiography using the SHAPE method, already proven in a canine model and tested in a human pilot study can be used as a surrogate for cardiac catheterization with sufficient accuracy to allow clinical applicability in humans."}, "conditionsModule": {"conditions": ["Cardiac Catheterization", "Blood Pressure", "Heart Ventricles", "Echocardiography", "Heart Failure"], "keywords": ["pressure measurements", "blood pressure", "contrast echocardiography", "ventricular pressures", "catheterization"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "NA", "interventionModel": "SINGLE_GROUP", "primaryPurpose": "DIAGNOSTIC", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 80, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Sonazoid for pressure measurements", "type": "EXPERIMENTAL", "description": "48 \u00b5l of Sonazoid microbubbles (GE Healthcare, Oslo, Norway) will be co-infused at a rate of 0.024 \u00b5l/kg body weight/minute together with a 0.9% sodium chloride solution infused at a rate of at least 2 ml/min.", "interventionNames": ["Drug: Sonazoid"]}], "interventions": [{"type": "DRUG", "name": "Sonazoid", "description": "Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Sonazoid infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure, SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.", "armGroupLabels": ["Sonazoid for pressure measurements"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Agreement Between SHAPE and Pressure Catheter Measurements", "description": "The Pearson correlation coefficient was computed between the simultaneously acquired subharmonic signal and pressure catheter data (i.e., waveforms) for each participant. The Pearson correlation coefficient was used for comparing waveforms given the underlying data and pressure values used for comparisons followed a normal distribution. Values reported will be the mean Pearson correlation coefficient values between the subharmonic waveforms and pressure catheter waveforms obtained.", "timeFrame": "up to 1 day"}, {"measure": "Error Between SHAPE and Pressure Catheter Measurements", "description": "Based on the distribution of the differences in cardiac pressure values obtained using the SHAPE technique and the clinical pressure catheter, either a two-tailed paired t test (normal distribution) or Wilcoxon signed rank test (nonnormal distribution) was used to compare the SHAPE technique to the reference standard. Bonferroni corrections were used for multiple comparisons", "timeFrame": "up to 1 day"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Be scheduled for cardiac catheterization procedure.\n* Be at least 18 years of age.\n* Be medically stable.\n* If a female of child-bearing potential, must have a negative pregnancy test.\n* Be conscious and able to comply with study procedures.\n* Have signed Informed Consent to participate in the study.\n\nExclusion Criteria:\n\n* Clinically unstable patients, e.g., those who are clinically in decompensated heart failure or having active chest pain or presenting for admission with an unstable anginal syndrome\n* Patients in whom introduction of a catheter into the left ventricle is contraindicated or would potentially be dangerous, e.g., patients with active ventricular arrhythmias or with significant aortic valve stenosis where crossing the aortic valve may be difficult and not clinically necessary\n* Females who are pregnant or nursing.\n* Patients not scheduled for cardiac catheterization procedure.\n* Patients who have received an investigational drug in the 30 days before, or will receive one within 72 h after, study drug administration.\n* Patients currently on chemotherapy or with other primary cancers requiring treatment.\n* Patients who are medically unstable, patients who are seriously or terminally ill, and patients whose clinical course is unpredictable.\n* Patients with a history of anaphylactic allergy to eggs or egg products, manifested by one or more of the following symptoms: generalised urticaria, difficulty in breathing, swelling of the mouth and throat, hypotension, or shock. (Subjects with nonanaphylactic allergies to eggs or egg products may be enrolled in the study, but must be watched carefully for 1 h following the administration of SONAZOID).\n* Patients with congenital heart defects.\n* Patients with severe emphysema, pulmonary vasculitis, or a history of pulmonary emboli.\n* Patients with respiratory distress syndrome or a contraindication to pharmacological vasodilator stress agents.\n* Patients with thrombosis within the hepatic, portal, or mesenteric veins.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "21 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Jaydev K Dave", "affiliation": "Thomas Jefferson University", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Thomas Jefferson University and Thomas Jefferson University Hospital", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19107", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}]}, "referencesModule": {"references": [{"pmid": "21989870", "type": "BACKGROUND", "citation": "Dave JK, Halldorsdottir VG, Eisenbrey JR, Liu JB, McDonald ME, Dickie K, Leung C, Forsberg F. Noninvasive estimation of dynamic pressures in vitro and in vivo using the subharmonic response from microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control. 2011 Oct;58(10):2056-66. doi: 10.1109/TUFFC.2011.2056."}, {"pmid": "22724314", "type": "BACKGROUND", "citation": "Dave JK, Halldorsdottir VG, Eisenbrey JR, Forsberg F. Processing of subharmonic signals from ultrasound contrast agents to determine ambient pressures. Ultrason Imaging. 2012 Apr;34(2):81-92. doi: 10.1177/016173461203400202."}, {"pmid": "23347593", "type": "BACKGROUND", "citation": "Dave JK, Halldorsdottir VG, Eisenbrey JR, Merton DA, Liu JB, Machado P, Zhao H, Park S, Dianis S, Chalek CL, Thomenius KE, Brown DB, Forsberg F. On the implementation of an automated acoustic output optimization algorithm for subharmonic aided pressure estimation. Ultrasonics. 2013 Apr;53(4):880-8. doi: 10.1016/j.ultras.2012.12.010. Epub 2013 Jan 2."}, {"pmid": "22561300", "type": "BACKGROUND", "citation": "Dave JK, Halldorsdottir VG, Eisenbrey JR, Raichlen JS, Liu JB, McDonald ME, Dickie K, Wang S, Leung C, Forsberg F. Subharmonic microbubble emissions for noninvasively tracking right ventricular pressures. Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H126-32. doi: 10.1152/ajpheart.00560.2011. Epub 2012 May 4."}, {"pmid": "22239898", "type": "BACKGROUND", "citation": "Dave JK, Halldorsdottir VG, Eisenbrey JR, Raichlen JS, Liu JB, McDonald ME, Dickie K, Wang S, Leung C, Forsberg F. Noninvasive LV pressure estimation using subharmonic emissions from microbubbles. JACC Cardiovasc Imaging. 2012 Jan;5(1):87-92. doi: 10.1016/j.jcmg.2011.08.017."}, {"pmid": "23525208", "type": "BACKGROUND", "citation": "Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Miller C, Gonzalez JM, Machado P, Park S, Dianis S, Chalek CL, Kim CE, Baliff JP, Thomenius KE, Brown DB, Navarro V, Forsberg F. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology. 2013 Aug;268(2):581-8. doi: 10.1148/radiol.13121769. Epub 2013 Mar 22."}, {"pmid": "16060506", "type": "BACKGROUND", "citation": "Forsberg F, Liu JB, Shi WT, Furuse J, Shimizu M, Goldberg BB. In vivo pressure estimation using subharmonic contrast microbubble signals: proof of concept. IEEE Trans Ultrason Ferroelectr Freq Control. 2005 Apr;52(4):581-3. doi: 10.1109/tuffc.2005.1428040."}, {"pmid": "21842580", "type": "BACKGROUND", "citation": "Halldorsdottir VG, Dave JK, Leodore LM, Eisenbrey JR, Park S, Hall AL, Thomenius K, Forsberg F. Subharmonic contrast microbubble signals for noninvasive pressure estimation under static and dynamic flow conditions. Ultrason Imaging. 2011 Jul;33(3):153-64. doi: 10.1177/016173461103300301."}, {"pmid": "10320317", "type": "BACKGROUND", "citation": "Shi WT, Forsberg F, Raichlen JS, Needleman L, Goldberg BB. Pressure dependence of subharmonic signals from contrast microbubbles. Ultrasound Med Biol. 1999 Feb;25(2):275-83. doi: 10.1016/s0301-5629(98)00163-x."}, {"pmid": "24856899", "type": "BACKGROUND", "citation": "Halldorsdottir VG, Dave JK, Eisenbrey JR, Machado P, Zhao H, Liu JB, Merton DA, Forsberg F. Subharmonic aided pressure estimation for monitoring interstitial fluid pressure in tumours--in vitro and in vivo proof of concept. Ultrasonics. 2014 Sep;54(7):1938-44. doi: 10.1016/j.ultras.2014.04.022. Epub 2014 May 6."}, {"pmid": "35079778", "type": "DERIVED", "citation": "Esposito C, Machado P, Cohen IS, Mehrotra P, Savage M, Fischman D, Davis M, Ruggiero N, Walinsky P, McDonald ME, Dickie K, Forsberg F, Dave JK. Comparing Central Aortic Pressures Obtained Using a SphygmoCor Device to Pressures Obtained Using a Pressure Catheter. Am J Hypertens. 2022 May 10;35(5):397-406. doi: 10.1093/ajh/hpac010."}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "This project will generate pressure values in the aorta, and left and right ventricles using the proposed research method (i.e., SHAPE) and using the standard of care (i.e., catheter based pressure values). Additionally peripheral and central pressures will be generated. All of the pressure values will be made available. Further, all ultrasound data obtained for SHAPE measurements will be made available after anonymizing the data-set to remove any patient information", "infoTypes": ["CSR"], "timeFrame": "2018-08-01 (anticipated) or starting 6 months after publication", "accessCriteria": "Accessible research platform"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Sonazoid for Pressure Measurements", "description": "48 \u00b5l of Sonazoid microbubbles (GE Healthcare, Oslo, Norway) will be co-infused at a rate of 0.024 \u00b5l/kg body weight/minute together with a 0.9% sodium chloride solution infused at a rate of at least 2 ml/min.\n\nSonazoid: Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Sonazoid infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure, SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "80"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "71"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "9"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Sonazoid for Pressure Measurements", "description": "48 \u00b5l of Sonazoid microbubbles (GE Healthcare, Oslo, Norway) will be co-infused at a rate of 0.024 \u00b5l/kg body weight/minute together with a 0.9% sodium chloride solution infused at a rate of at least 2 ml/min.\n\nSonazoid: Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Sonazoid infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure, SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "80"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "63", "lowerLimit": "32", "upperLimit": "82"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "31"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "49"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "White Non Hispanic", "categories": [{"measurements": [{"groupId": "BG000", "value": "61"}]}]}, {"title": "Black or African American", "categories": [{"measurements": [{"groupId": "BG000", "value": "15"}]}]}, {"title": "Asian", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}]}]}, {"title": "Hispanic or Latino", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}, {"title": "Other", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "80"}]}]}]}, {"title": "Body Mass Index", "paramType": "MEAN", "dispersionType": "FULL_RANGE", "unitOfMeasure": "kg/m^2", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "30", "lowerLimit": "15", "upperLimit": "49"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Agreement Between SHAPE and Pressure Catheter Measurements", "description": "The Pearson correlation coefficient was computed between the simultaneously acquired subharmonic signal and pressure catheter data (i.e., waveforms) for each participant. The Pearson correlation coefficient was used for comparing waveforms given the underlying data and pressure values used for comparisons followed a normal distribution. Values reported will be the mean Pearson correlation coefficient values between the subharmonic waveforms and pressure catheter waveforms obtained.", "populationDescription": "Data was not acquired in all the enrolled patients due to health concerns during the catheterization procedure, software and/or hardware issues related to the data acquisition process, patient scheduling and/or arrival of emergency cases, and withdrawn consent before the procedure.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "Correlation coefficient value", "timeFrame": "up to 1 day", "groups": [{"id": "OG000", "title": "For Data From Right Ventricle", "description": "For cases in which data was acquired from right ventricle"}, {"id": "OG001", "title": "For Data From Left Ventricle", "description": "For cases in which data was acquired from left ventricle"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "22"}, {"groupId": "OG001", "value": "25"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.8", "spread": "0.1"}, {"groupId": "OG001", "value": "-0.8", "spread": "0.1"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "OTHER", "nonInferiorityComment": "Correlation analysis", "paramType": "Pearson Correlation Coefficient", "paramValue": "-0.8", "ciNumSides": "TWO_SIDED", "dispersionType": "STANDARD_DEVIATION", "dispersionValue": "0.1"}]}, {"type": "PRIMARY", "title": "Error Between SHAPE and Pressure Catheter Measurements", "description": "Based on the distribution of the differences in cardiac pressure values obtained using the SHAPE technique and the clinical pressure catheter, either a two-tailed paired t test (normal distribution) or Wilcoxon signed rank test (nonnormal distribution) was used to compare the SHAPE technique to the reference standard. Bonferroni corrections were used for multiple comparisons", "populationDescription": "LV data were acquired in 25 participants; error calculations were not performed in seven (of 25) participants because the subharmonic signal range was less than the noise threshold of 2.5 dB. RV data were acquired in 22 participants. From this set of 22 participants, the aortic data were not acquired in most, as the participants were scheduled for right heart catheterization only. Due to this, we could only process data from the participants with aortic pressure measurements available.", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "mmHg", "timeFrame": "up to 1 day", "groups": [{"id": "OG000", "title": "For Data From Left Ventricle - Errors in Mean Diastolic Pressure", "description": "Errors in mean diastolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique"}, {"id": "OG001", "title": "For Data From Left Ventricle - Errors in Minimum Diastolic Pressure", "description": "Errors in minimum diastolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique"}, {"id": "OG002", "title": "For Data From Left Ventricle - Errors in End Diastolic Pressure", "description": "Errors in end diastolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique"}, {"id": "OG003", "title": "For Data From Right Ventricle", "description": "Errors in systolic pressures between pressures obtained using the pressure catheter and using the SHAPE technique"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "18"}, {"groupId": "OG001", "value": "18"}, {"groupId": "OG002", "value": "18"}, {"groupId": "OG003", "value": "8"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.4", "spread": "7.4"}, {"groupId": "OG001", "value": "6.6", "spread": "8.3"}, {"groupId": "OG002", "value": "5.8", "spread": "7.5"}, {"groupId": "OG003", "value": "1.2", "spread": "1.5"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "During data acquisition after Sonazoid infusion (5-10 minutes) and when the patients were observed in the recovery area after the procedure for up to 60 minutes after the procedure.", "eventGroups": [{"id": "EG000", "title": "Sonazoid for Pressure Measurements", "description": "48 \u00b5l of Sonazoid microbubbles (GE Healthcare, Oslo, Norway) will be co-infused at a rate of 0.024 \u00b5l/kg body weight/minute together with a 0.9% sodium chloride solution infused at a rate of at least 2 ml/min.\n\nSonazoid: Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Sonazoid infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure, SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.", "deathsNumAffected": 0, "deathsNumAtRisk": 71, "seriousNumAffected": 0, "seriousNumAtRisk": 71, "otherNumAffected": 0, "otherNumAtRisk": 71}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Jaydev Dave", "organization": "Thomas Jefferson University", "email": "dave.jaydev@mayo.edu", "phone": "2158684795"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2016-03-09", "uploadDate": "2021-12-13T16:11", "filename": "Prot_SAP_000.pdf", "size": 339246}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "submissionTracking": {"firstMcpInfo": {"postDateStruct": {"date": "2022-01-18", "type": "ACTUAL"}}}}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"browseLeaves": [{"id": "M21860", "name": "Pharmaceutical Solutions", "relevance": "LOW"}], "browseBranches": [{"abbrev": "PhSol", "name": "Pharmaceutical Solutions"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}